Suppression of colds in human volunteers challenged with rhinovirus by a new synthetic drug (R61837).

This report describes double-blind placebo-controlled trials of a new synthetic antirhinovirus drug, R61837, which showed it to be effective in suppressing colds in human volunteers challenged with rhinovirus type 9. In one trial, R61837 was given by intranasal spray six times a day, commencing 28 h...

Täydet tiedot

Bibliografiset tiedot

Julkaisussa:	Antimicrob Agents Chemother
Päätekijät:	al-Nakib, W, Higgins, P G, Barrow, G I, Tyrrell, D A, Andries, K, Vanden Bussche, G, Taylor, N, Janssen, P A
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	American Society for Microbiology (ASM) 1989
Aiheet:	Research Article
Linkit:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC172472/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2543283/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.33.4.522
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!